ROME GS System Study for diabetes glucose monitoring
Part of Hormones & metabolism clinical trials.
This study tests the ROME GS System, a glucose monitoring device that measures blood sugar levels. The system includes a sensor placed under the skin and a transmitter worn on the body. If you have diabetes and want to help evaluate a new way to track your blood sugar, this trial may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with diabetes for at least 1 year
- You have not had a severe low blood sugar episode (causing loss of consciousness or seizure) in the past 6 months
- You do not have a serious heart condition, recent heart attack or stroke, or very high blood pressure
- You are able to wear a sensor on your upper arm and are willing to follow the study procedures
- You are not pregnant, trying to become pregnant, or breastfeeding (if you can become pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study tests a new wearable device (Argus 2.0) that tracks glucose levels continuously for up to 15 days. It aims to see how well it works compared to standard monitors, which may help you manage your diabetes or prediabetes more easily.
This study tests a new continuous glucose monitor (CGM) that checks your sugar levels day and night without frequent finger pricks. It may help you manage your diabetes better by showing glucose trends and alerts.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.